NO961006L - Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene - Google Patents

Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene

Info

Publication number: NO961006L
Authority: NO; Norway
Prior art keywords: phosphonomononucleic; acids; compounds; processes; preparation
Prior art date: 1995-03-13

Application number

NO961006A

Other languages

English (en)

Other versions

NO961006D0 (no

NO328646B1 (no

Inventor

Anuschirwan Peyman

Eugen Uhlmann

Gerhard Breipohl

Holger Wallmeier

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-13

Filing date

1996-03-12

Publication date

1996-09-16

1995-03-13 Priority claimed from DE19508923A external-priority patent/DE19508923A1/de

1995-11-24 Priority claimed from DE1995143865 external-priority patent/DE19543865A1/de

1996-03-12 Application filed by Hoechst Ag filed Critical Hoechst Ag

1996-03-12 Publication of NO961006D0 publication Critical patent/NO961006D0/no

1996-09-16 Publication of NO961006L publication Critical patent/NO961006L/no

2010-04-19 Publication of NO328646B1 publication Critical patent/NO328646B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4087—Esters with arylalkanols
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C07K14/003—Peptide-nucleic acids (PNAs)

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Genetics & Genomics (AREA)
Oncology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO19961006A 1995-03-13 1996-03-12 Fosfonomononukleinsyrer, anvendelse samt fremgangsmater for fremstilling NO328646B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19508923A DE19508923A1 (de)	1995-03-13	1995-03-13	Phosphonomonoesternukleinsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
DE1995143865 DE19543865A1 (de)	1995-11-24	1995-11-24	Phosphonomonoesternukleinsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (3)

Publication Number	Publication Date
NO961006D0 NO961006D0 (no)	1996-03-12
NO961006L true NO961006L (no)	1996-09-16
NO328646B1 NO328646B1 (no)	2010-04-19

Family

ID=26013308

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19961006A NO328646B1 (no)	1995-03-13	1996-03-12	Fosfonomononukleinsyrer, anvendelse samt fremgangsmater for fremstilling

Country Status (21)

Country	Link
US (2)	US5874553A (no)
EP (1)	EP0739898B1 (no)
JP (1)	JP3917680B2 (no)
KR (1)	KR100434213B1 (no)
CN (1)	CN1060781C (no)
AR (1)	AR002714A1 (no)
AT (1)	ATE206131T1 (no)
AU (1)	AU706470B2 (no)
BR (1)	BR9600993B1 (no)
CA (1)	CA2171589C (no)
CZ (1)	CZ292037B6 (no)
DE (1)	DE59607750D1 (no)
DK (1)	DK0739898T3 (no)
ES (1)	ES2165446T3 (no)
HU (1)	HUP9600647A3 (no)
IL (1)	IL117423A (no)
NO (1)	NO328646B1 (no)
NZ (1)	NZ286150A (no)
PL (1)	PL184920B1 (no)
PT (1)	PT739898E (no)
UA (1)	UA44253C2 (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5855911A (en) *	1995-08-29	1999-01-05	Board Of Regents, The University Of Texas System	Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
US20050053976A1 (en) *	1996-06-06	2005-03-10	Baker Brenda F.	Chimeric oligomeric compounds and their use in gene modulation
US20040171031A1 (en) *	1996-06-06	2004-09-02	Baker Brenda F.	Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
US20040147022A1 (en) *	1996-06-06	2004-07-29	Baker Brenda F.	2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
US20040203024A1 (en) *	1996-06-06	2004-10-14	Baker Brenda F.	Modified oligonucleotides for use in RNA interference
US20050119470A1 (en) *	1996-06-06	2005-06-02	Muthiah Manoharan	Conjugated oligomeric compounds and their use in gene modulation
US9096636B2 (en)	1996-06-06	2015-08-04	Isis Pharmaceuticals, Inc.	Chimeric oligomeric compounds and their use in gene modulation
US7812149B2 (en) *	1996-06-06	2010-10-12	Isis Pharmaceuticals, Inc.	2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US5898031A (en) *	1996-06-06	1999-04-27	Isis Pharmaceuticals, Inc.	Oligoribonucleotides for cleaving RNA
US20070275921A1 (en) *	1996-06-06	2007-11-29	Isis Pharmaceuticals, Inc.	Oligomeric Compounds That Facilitate Risc Loading
US6977244B2 (en) *	1996-10-04	2005-12-20	Board Of Regents, The University Of Texas Systems	Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
WO1998035753A1 (de) *	1997-02-17	1998-08-20	GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF)	Vorrichtung für eine automatisierte chemische synthese
CA2290614C (en) *	1997-05-14	2010-09-21	Morphochem Ag	Process for the preparation of polymers having nucleobases as side groups
DE19741738A1 (de) *	1997-09-22	1999-03-25	Hoechst Ag	Linker-Nucleosid, seine Herstellung und Verwendung
DE19741715A1 (de)	1997-09-22	1999-03-25	Hoechst Ag	Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
US7285288B1 (en)	1997-10-03	2007-10-23	Board Of Regents, The University Of Texas System	Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en)	1997-10-03	2010-04-27	Board Of Regents, The University Of Texas System	Small oligonucleotides with anti-tumor activity
US7098192B2 (en)	1999-04-08	2006-08-29	Isis Pharmaceuticals, Inc.	Antisense oligonucleotide modulation of STAT3 expression
DE19935303A1 (de)	1999-07-28	2001-02-08	Aventis Pharma Gmbh	Oligonukleotide zur Inhibierung der Expression von humanem eg5
GB9929487D0 (en) *	1999-12-15	2000-02-09	Zeneca Ltd	Antisense oligonucleotides
EP1263773A4 (en)	2000-03-14	2005-08-31	Active Motif	OLIGONUCLEOTIDE ANALOGUES, METHODS OF SYNTHESIS AND METHODS OF IMPLEMENTATION
US20040014644A1 (en) *	2000-03-14	2004-01-22	Vladimir Efimov	Oligonucleotide analogues and methods of use for modulating gene expression
US6962906B2 (en) *	2000-03-14	2005-11-08	Active Motif	Oligonucleotide analogues, methods of synthesis and methods of use
DE10019135A1 (de) *	2000-04-18	2001-10-31	Aventis Pharma Gmbh	Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
DE10019136A1 (de) *	2000-04-18	2001-10-31	Aventis Pharma Gmbh	Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
EP2957568B1 (en) *	2002-11-05	2016-12-21	Ionis Pharmaceuticals, Inc.	Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
US9150606B2 (en) *	2002-11-05	2015-10-06	Isis Pharmaceuticals, Inc.	Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
US9150605B2 (en)	2002-11-05	2015-10-06	Isis Pharmaceuticals, Inc.	Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
WO2004044138A2 (en)	2002-11-05	2004-05-27	Isis Pharmaceuticals, Inc.	Chimeric oligomeric compounds and their use in gene modulation
EP1660512A4 (en) *	2003-06-02	2009-12-23	Isis Pharmaceuticals Inc	SYNTHESIS OF OLIGONUCLEOTIDES USING ALTERNATIVE SOLVENTS
CA2524495A1 (en)	2003-06-03	2005-01-13	Eli Lilly And Company	Modulation of survivin expression
US20060241072A1 (en) *	2003-06-20	2006-10-26	Isis Pharmaceuticals, Inc.	Oligomeric compounds for use in gene modulation
CA2533701A1 (en)	2003-07-31	2005-02-17	Isis Pharmaceuticals, Inc.	Oligomeric compounds and compositions for use in modulation of small non-coding rnas
US20050053981A1 (en) *	2003-09-09	2005-03-10	Swayze Eric E.	Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
JP5379347B2 (ja)	2003-09-18	2013-12-25	アイシスファーマシューティカルズ，インコーポレーテッド	４’−チオヌクレオシドおよびオリゴマー化合物
US8569474B2 (en) *	2004-03-09	2013-10-29	Isis Pharmaceuticals, Inc.	Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8790919B2 (en)	2004-03-15	2014-07-29	Isis Pharmaceuticals, Inc.	Compositions and methods for optimizing cleavage of RNA by RNase H
JP2008501694A (ja) *	2004-06-03	2008-01-24	アイシスファーマシューティカルズ、インク．	遺伝子調節の使用のために個別に修飾された鎖を有する二本鎖組成物
EP1766052A4 (en) *	2004-06-03	2009-12-16	Isis Pharmaceuticals Inc	OLIGOMERIC CHIMERIC COMPOSITIONS WITH BRECH
US8394947B2 (en) *	2004-06-03	2013-03-12	Isis Pharmaceuticals, Inc.	Positionally modified siRNA constructs
US7884086B2 (en) *	2004-09-08	2011-02-08	Isis Pharmaceuticals, Inc.	Conjugates for use in hepatocyte free uptake assays
US20060281100A1 (en) *	2005-06-14	2006-12-14	Shen Gene G	Thiotriphosphate nucleotide dye terminators
AU2009331298B2 (en) *	2008-12-22	2015-04-30	Pola Chemical Industries Inc.	Melanin production inhibitor
WO2010090762A1 (en)	2009-02-04	2010-08-12	Rxi Pharmaceuticals Corporation	Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
JP2023502436A (ja) *	2019-11-20	2023-01-24	ユニバーサルシーケンシングテクノロジーコーポレイション	分子エレクトロニクスのための操作されたｄｎａ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4350704A (en) *	1980-10-06	1982-09-21	Warner-Lambert Company	Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4344949A (en) *	1980-10-03	1982-08-17	Warner-Lambert Company	Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4374847A (en) *	1980-10-27	1983-02-22	Ciba-Geigy Corporation	1-Carboxyalkanoylindoline-2-carboxylic acids
US5264562A (en) *	1989-10-24	1993-11-23	Gilead Sciences, Inc.	Oligonucleotide analogs with novel linkages
DE4016596A1 (de) *	1990-05-23	1991-11-28	Hoechst Ag	Ein neues kupplungsreagenz fuer die peptidsynthese
NZ245720A (en) *	1992-01-22	1995-12-21	Hoechst Ag	Oligonucleotide analogues; use as gene expression inhibitor or dna probe
US5434257A (en) *	1992-06-01	1995-07-18	Gilead Sciences, Inc.	Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages
JPH08508492A (ja) *	1993-03-30	1996-09-10	スターリングウィンスロップインコーポレイティド	非環式ヌクレオシド類似体及びそれらを含むオリゴヌクレオチド配列
DE69407032T2 (de) *	1993-03-31	1998-07-02	Sanofi Sa	Oligonucleotide mit amidverkettungen die phosphoesterverkettungen einsetzen
CA2159723A1 (en) *	1993-04-01	1994-10-13	T. Y. Shen	7-azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents
DE4321946A1 (de) *	1993-07-01	1995-01-12	Hoechst Ag	Methylphosphonsäureester, Verfahren zu deren Herstellung und deren Verwendung
DE4408528A1 (de) *	1994-03-14	1995-09-28	Hoechst Ag	Peptid-Oligonucleotid-Derivate, deren Herstellung und Verwendung

1996
- 1996-03-07 PT PT96103533T patent/PT739898E/pt unknown
- 1996-03-07 AT AT96103533T patent/ATE206131T1/de active
- 1996-03-07 EP EP96103533A patent/EP0739898B1/de not_active Expired - Lifetime
- 1996-03-07 DE DE59607750T patent/DE59607750D1/de not_active Expired - Lifetime
- 1996-03-07 ES ES96103533T patent/ES2165446T3/es not_active Expired - Lifetime
- 1996-03-07 DK DK96103533T patent/DK0739898T3/da active
- 1996-03-10 IL IL117423A patent/IL117423A/en not_active IP Right Cessation
- 1996-03-11 CZ CZ1996743A patent/CZ292037B6/cs not_active IP Right Cessation
- 1996-03-11 US US08/613,417 patent/US5874553A/en not_active Expired - Lifetime
- 1996-03-11 NZ NZ286150A patent/NZ286150A/en not_active IP Right Cessation
- 1996-03-11 AR ARP960101703A patent/AR002714A1/es unknown
- 1996-03-12 BR BRPI9600993-4A patent/BR9600993B1/pt active IP Right Grant
- 1996-03-12 PL PL96313207A patent/PL184920B1/pl unknown
- 1996-03-12 UA UA96030965A patent/UA44253C2/uk unknown
- 1996-03-12 CA CA2171589A patent/CA2171589C/en not_active Expired - Fee Related
- 1996-03-12 NO NO19961006A patent/NO328646B1/no not_active IP Right Cessation
- 1996-03-12 AU AU48028/96A patent/AU706470B2/en not_active Ceased
- 1996-03-13 KR KR1019960006588A patent/KR100434213B1/ko not_active Expired - Fee Related
- 1996-03-13 CN CN96100508A patent/CN1060781C/zh not_active Expired - Fee Related
- 1996-03-13 JP JP08480896A patent/JP3917680B2/ja not_active Expired - Fee Related
- 1996-03-13 HU HU9600647A patent/HUP9600647A3/hu unknown
1998
- 1998-11-20 US US09/196,132 patent/US6127346A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
PL184920B1 (pl)	2003-01-31
ATE206131T1 (de)	2001-10-15
EP0739898A3 (de)	1998-09-16
JP3917680B2 (ja)	2007-05-23
HU9600647D0 (en)	1996-05-28
CZ292037B6 (cs)	2003-07-16
EP0739898B1 (de)	2001-09-26
US5874553A (en)	1999-02-23
AR002714A1 (es)	1998-04-29
NO961006D0 (no)	1996-03-12
DK0739898T3 (da)	2001-12-10
PT739898E (pt)	2002-03-28
PL313207A1 (en)	1996-09-16
CA2171589C (en)	2011-05-10
BR9600993A (pt)	1997-12-30
CZ74396A3 (en)	1996-10-16
US6127346A (en)	2000-10-03
JPH08259579A (ja)	1996-10-08
ES2165446T3 (es)	2002-03-16
KR960034213A (ko)	1996-10-22
NO328646B1 (no)	2010-04-19
IL117423A (en)	2006-08-20
KR100434213B1 (ko)	2004-09-10
BR9600993B1 (pt)	2010-05-18
CN1060781C (zh)	2001-01-17
AU4802896A (en)	1996-09-26
EP0739898A2 (de)	1996-10-30
IL117423A0 (en)	1996-07-23
HUP9600647A3 (en)	1998-04-28
HUP9600647A1 (en)	1997-05-28
UA44253C2 (uk)	2002-02-15
HK1012398A1 (en)	1999-07-30
AU706470B2 (en)	1999-06-17
CA2171589A1 (en)	1996-09-14
NZ286150A (en)	1998-07-28
CN1138588A (zh)	1996-12-25
DE59607750D1 (de)	2001-10-31

Publication	Publication Date	Title
NO961006D0 (no)	1996-03-12	Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO305833B1 (no)	1999-08-02	Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene
FI973281L (fi)	1997-08-08	Menetelmä tiettyjen atsasykloheksapeptidien valmistamiseksi
NO976063D0 (no)	1997-12-23	Fremgangsmåte for behandling av diabetes
NO981800L (no)	1998-06-11	FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO306620B1 (no)	1999-11-29	Fremgangsmåte for fremstilling av polydimetylsiloksaner
FI971268A7 (fi)	1997-03-26	Menetelmä 1,3-alkaanidiolien ja 3-hydroksialdehydien valmistamiseksi
NO982237L (no)	1998-07-10	FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO304110B1 (no)	1998-10-26	FremgangsmÕte for fremstilling av glutardialdehyd
FI971267A7 (fi)	1997-03-26	Menetelmä 1,3-alkaanidiolien ja 3-hydroksialdehydien valmistamiseksi
NO996432D0 (no)	1999-12-23	Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO985535L (no)	1999-01-27	FremgangsmÕte for fremstilling av 1,3-alkandioler
NO307080B1 (no)	2000-02-07	Fremgangsmåte for fremstilling av katalysatorer og anvendelse derav
FI964410A7 (fi)	1996-11-01	Menetelmä 4-amino-delta4-3-ketosteroidien valmistamiseksi 4-nitro-delt a4-3-ketosteroidien kautta
NO971419L (no)	1997-03-25	Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
FI940551A0 (fi)	1994-02-07	Menetelmä fenyylibentsamidijohdannaisten valmistamiseksi
FI953617A7 (fi)	1995-07-28	Menetelmä substituoitujen 4-hydroksikumariinien valmistamiseksi
NO994557D0 (no)	1999-09-20	Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO20003077L (no)	2000-06-15	FremgangsmÕte for fremstilling av klorbenzooksazolen
NO972129D0 (no)	1997-05-07	Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
FI951441L (fi)	1995-09-29	Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi
NO20002476L (no)	2000-05-12	FremgangsmÕte for fremstilling av formylimidazoler
NO964519D0 (no)	1996-10-24	Fremgangsmåte for fremstilling av chitosanalkylderivater
FI970039A7 (fi)	1997-01-03	Menetelmä 5-aryyli-2,4-dialkyyli-3H-1,2,3-triatsoli-3-tionien valmista miseksi
FI20040505A7 (fi)	2004-04-06	Menetelmä 1,3-dihydro-6-hydroksi-2H-indol-2-oni-johdannaisten valmistamiseksi

Legal Events

Date	Code	Title	Description
2014-11-03	MM1K	Lapsed by not paying the annual fees